Respiratory Medicine
Volume 100, Issue 8 , Pages 1392-1396, August 2006

A comparison of exhaled nitric oxide measurements performed using three different analysers

  • Zoë Borrill

      Affiliations

    • Medicines Evaluation Unit, North West Lung Centre, Wythenshawe Hospital, Southmoor Road., Manchester M23 9LT, UK
    • Corresponding Author InformationCorresponding author. Tel.: +441612912239; fax: +441612912243.
  • ,
  • David Clough

      Affiliations

    • Medicines Evaluation Unit, North West Lung Centre, Wythenshawe Hospital, Southmoor Road., Manchester M23 9LT, UK
  • ,
  • Nick Truman

      Affiliations

    • Medicines Evaluation Unit, North West Lung Centre, Wythenshawe Hospital, Southmoor Road., Manchester M23 9LT, UK
  • ,
  • Julie Morris

      Affiliations

    • Medical Statistics, Wythenshawe Hospital, Southmoor Road, Manchester M23 9LT, UK
  • ,
  • Stephen Langley

      Affiliations

    • Medicines Evaluation Unit, North West Lung Centre, Wythenshawe Hospital, Southmoor Road., Manchester M23 9LT, UK
  • ,
  • Dave Singh

      Affiliations

    • Medicines Evaluation Unit, North West Lung Centre, Wythenshawe Hospital, Southmoor Road., Manchester M23 9LT, UK

Received 14 February 2005; accepted 21 November 2005. published online 23 January 2006.

Summary 

Introduction

Exhaled nitric oxide (NO) is an established technique for monitoring airway inflammation. We have compared exhaled NO measurements from 3 different analysers; Ecomedics (E), Niox (N) and Logan (L).

Methods

Thirty subjects (10 non-smoking healthy subjects, 10 non-smoking patients with asthma and 10 ex-smoking COPD patients) performed 3 repeated measurements of exhaled NO at a flow rate of 50ml/s on each of the 3 analysers. Within analyser variability was determined by calculating the repeatability coefficient for each analyser. Differences between analysers were assessed by (1) the differences between group means and (2) the Bland Altman method to estimate the variability expected for an individual using the 3 analysers.

Results

The repeatability coefficients (expressed as ratios) were 1.12, 1.19 and 1.19 for N, E and L, respectively. There were significant differences between analysers; the Logan analyser gave the highest group mean values and Ecomedics gave the lowest group mean values. Differences between analysers were observed in all subject groups (healthy, asthma, COPD). Similar results were obtained in the 3 groups when analysed separately. Bland Altman analysis gave the following ratios [data are mean ratio (95% limits of agreement)]; N:E 1.59 (1.02–2.50), L:N 1.23 (0.72–2.13), L:E 1.96 (1.09–3.57).

Conclusion

Our findings indicate that exhaled NO measurements in healthy subjects and patients with airways disease differ according to the type of analyser used.

Keywords: Exhaled nitric oxide, Chronic obstructive pulmonary disease, Asthma

Abbreviations: COPD, chronic obstructive pulmonary disease, FEV1, forced expiratory volume in 1s, NO, nitric oxide, ppb, parts per billion, ppm, parts per million

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0954-6111(05)00508-1

doi:10.1016/j.rmed.2005.11.018

Respiratory Medicine
Volume 100, Issue 8 , Pages 1392-1396, August 2006